Wen Jianting, Liu Jian, Wan Lei, Wang Fanfan
Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
Institute of Rheumatology, Anhui Academy of Chinese Medicine, Hefei, Anhui, China.
Front Immunol. 2025 Jul 23;16:1620209. doi: 10.3389/fimmu.2025.1620209. eCollection 2025.
Rheumatoid arthritis (RA), a prevalent autoimmune disorder, imposes a substantial burden on global health due to its progressive disability and compromised patient well-being. Although the precise etiology of this condition is still not fully understood, current research implicates intricate interactions between dysregulated immune cells and pro-inflammatory mediators. Recent scientific advancements have highlighted the pathogenic significance of programmed cell death (PCD) mechanisms (including spanning apoptosis, autophagy, ferroptosis, necroptosis, senescence, and pyroptosis) in RA pathophysiology. Emerging evidence has established these cellular demise pathways as critical contributors to synovial inflammation and joint destruction. This comprehensive analysis systematically examined the mechanistic involvement of distinct cell death modalities in RA development, with particular focus on their regulatory interplay with non-coding RNAs (ncRNAs). Furthermore, the emerging therapeutic potential of traditional Chinese medicine (TCM) formulations in modulating these cell death networks was evaluated, ultimately proposing novel translational frameworks for targeted RA intervention.
类风湿性关节炎(RA)是一种常见的自身免疫性疾病,因其渐进性残疾和患者健康受损,给全球健康带来了沉重负担。尽管这种疾病的确切病因仍未完全明确,但目前的研究表明,免疫细胞失调与促炎介质之间存在复杂的相互作用。最近的科学进展突出了程序性细胞死亡(PCD)机制(包括细胞凋亡、自噬、铁死亡、坏死性凋亡、衰老和焦亡)在RA病理生理学中的致病意义。新出现的证据表明,这些细胞死亡途径是滑膜炎症和关节破坏的关键因素。本综合分析系统地研究了不同细胞死亡方式在RA发展中的机制参与,特别关注它们与非编码RNA(ncRNA)的调节相互作用。此外,还评估了中药配方在调节这些细胞死亡网络方面新出现的治疗潜力,最终提出了针对RA干预的新型转化框架。